Valneva SE (VALN)
NASDAQ·Healthcare·Biotechnology
$6.31
-4.32%
Mkt Cap $903.47M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+74.5%
Consensus $11.00 vs current $6.31
NASDAQ·Healthcare·Biotechnology
$6.31
-4.32%
Mkt Cap $903.47M
No recent rating data.
Price Target (4 analysts)
$11.00
Range $11.00 – $11.00
+74.5%
Consensus $11.00 vs current $6.31